CytoMed Therapeutics Ltd GDTC
Trading Information
- Previous Close Price
- $1.02
- Day Range
- $0.94–1.02
- 52-Week Range
- $0.00–3.68
- Bid/Ask
- $0.92 / $1.02
- Shares Outstanding
- 11.83M
- Market Cap
- $12.07M
- Volume/Avg
- 2,641 / 18,691
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 47.88
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 42
- Website
- https://w2.cytomed.sg
Valuation
|
Metric
|
GDTC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.41 |
Price/Sales | 47.88 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
GDTC
|
|---|---|
Quick Ratio | 3.14 |
Current Ratio | 5.17 |
Interest Coverage | −196.08 |
Quick Ratio
GDTC
Profitability
|
Metric
|
GDTC
|
|---|---|
Return on Assets (Normalized) | −39.95% |
Return on Equity (Normalized) | −47.75% |
Return on Invested Capital (Normalized) | −44.23% |
Return on Assets
GDTC
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|^x?c@>l | LOCK|>vB>s | $121B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|$<X<j! | LOCK|CbJY | $70B | |||
| argenx SE ADR
ARGX
| LOCK|$sTY$@H | LOCK|$< | $54B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|R!Cx#&g | LOCK|LX!p | $37B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|@%$#R?@ | LOCK|b@ | $37B | |||
| Moderna Inc
MRNA
| LOCK|V@J$d# | LOCK|@&K | $27B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|TSW&f^x! | LOCK|%Tzl | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|w#>J&J | LOCK|ZP | $23B | |||
| Incyte Corp
INCY
| LOCK|C#ZtP&J | LOCK|^Vy | $23B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|&NrLG?L | LOCK|&c | $16B |
United States